Hopkins Biotech Podcast kapak görseli

Hopkins Biotech Podcast

Hopkins Biotech Podcast

Yazan: Hopkins Biotech Podcast
Şimdi ücretsiz dinle, üyelik gerekmez

This Season's Biggest Deal | £0.99/mo for 3 months + £10 Audible bonus

£5.99/mo after 3 months - terms apply. Cancel monthly
Özet
Illuminating life science career opportunities outside of academia through the experiences of those who have been there before.© 2026 Hopkins Biotech Podcast Biological Sciences Career Success Economics Science
  • Sickle Cell Disease: New Wave of Gene Therapies
    1 Oct 2025

    Sickle cell disease was once considered an incurable disease, until recently. A wide variety of gene therapies have now become available, allowing patients with sickle cell disease to now have futures once thought unimaginable. In this podcast episode, we talk through these treatments and get expert advice on what these treatments mean for our future.

    Daha fazlasını göster Daha Az Göster
    39 dk.
  • Roivant: Reinventing the Paradigm of Conventional Drug Development
    5 Jan 2024

    Roivant Pharma is reinventing the discovery, development, and commercialization of new medicines. Mayukh Sukhatme, M.D. was recently appointed to Roivant's board of directors and has served as Roivant’s President and Chief Investment Officer since January 2021. He is responsible for identifying, performing diligence on, devising development strategies for, and transacting on new therapeutic programs for the company. He also informs Roivant’s view of its existing biopharmaceutical subsidiary companies for capital allocation decisions across the Roivant portfolio.

    Mayukh joined Roivant in 2015 and previously served as President of Roivant Pharma and as Chief Business Officer. Programs that he has in-licensed or acquired for Roivant have produced all 10 of Roivant’s positive Phase 3 studies and have garnered 6 FDA approvals. Before joining Roivant, Mayukh was a healthcare-focused analyst and portfolio manager for several large institutional investment firms, including both public markets and venture capital firms. He earned his M.D. from Harvard Medical School and his B.S. in Biology and B.S. in Literature from MIT.

    Hosted by Joe Varriale.

    Daha fazlasını göster Daha Az Göster
    51 dk.
  • Public Relations and Scientific Communications for Biotechnology with Ignacio Guerrero-Ros
    18 Dec 2023

    Dr. Ignacio Guerrero-Ros is an immunologist turned scientific communicator and biotech media innovator. Currently, he is an Assistant Vice President at Russo Partners, providing public and investor relations services to clients in the healthcare and technology industries. Originally from Spain, Ignacio earned his PhD in Immunology from Albert Einstein College of Medicine. Ignacio embraces the Hopkins Biotech Podcast's mission of the pursuit of alternative careers for PhD holders.

    In this episode, we discuss his ideas for how to find success beyond grad school and how he found a passion for science communication.

    Hosted by Joe Varriale.

    Daha fazlasını göster Daha Az Göster
    44 dk.
adbl_web_anon_alc_button_suppression_t1
Henüz yorum yok